Matches in Wikidata for { <http://www.wikidata.org/entity/Q51533517> ?p ?o ?g. }
- Q51533517 description "2011 nî lūn-bûn" @default.
- Q51533517 description "2011年の論文" @default.
- Q51533517 description "2011年学术文章" @default.
- Q51533517 description "2011年学术文章" @default.
- Q51533517 description "2011年学术文章" @default.
- Q51533517 description "2011年学术文章" @default.
- Q51533517 description "2011年学术文章" @default.
- Q51533517 description "2011年学术文章" @default.
- Q51533517 description "2011年學術文章" @default.
- Q51533517 description "2011年學術文章" @default.
- Q51533517 description "2011年學術文章" @default.
- Q51533517 description "2011年學術文章" @default.
- Q51533517 description "2011年學術文章" @default.
- Q51533517 description "2011년 논문" @default.
- Q51533517 description "article científic" @default.
- Q51533517 description "article scientific" @default.
- Q51533517 description "article scientifique" @default.
- Q51533517 description "articol științific" @default.
- Q51533517 description "articolo scientifico" @default.
- Q51533517 description "artigo científico" @default.
- Q51533517 description "artigo científico" @default.
- Q51533517 description "artigo científico" @default.
- Q51533517 description "artikel ilmiah" @default.
- Q51533517 description "artikull shkencor" @default.
- Q51533517 description "artikulong pang-agham" @default.
- Q51533517 description "artykuł naukowy" @default.
- Q51533517 description "artículo científico publicado en 2011" @default.
- Q51533517 description "artículu científicu" @default.
- Q51533517 description "bilimsel makale" @default.
- Q51533517 description "bài báo khoa học" @default.
- Q51533517 description "naučni članak" @default.
- Q51533517 description "scienca artikolo" @default.
- Q51533517 description "scientific article published on 17 October 2011" @default.
- Q51533517 description "scientific article published on 17 October 2011" @default.
- Q51533517 description "scientific article published on 17 October 2011" @default.
- Q51533517 description "teaduslik artikkel" @default.
- Q51533517 description "tieteellinen artikkeli" @default.
- Q51533517 description "tudományos cikk" @default.
- Q51533517 description "vedecký článok" @default.
- Q51533517 description "vetenskaplig artikel" @default.
- Q51533517 description "videnskabelig artikel" @default.
- Q51533517 description "vitenskapelig artikkel" @default.
- Q51533517 description "vitskapeleg artikkel" @default.
- Q51533517 description "vědecký článek" @default.
- Q51533517 description "wetenschappelijk artikel" @default.
- Q51533517 description "wissenschaftlicher Artikel" @default.
- Q51533517 description "επιστημονικό άρθρο" @default.
- Q51533517 description "мақолаи илмӣ" @default.
- Q51533517 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q51533517 description "научна статия" @default.
- Q51533517 description "научная статья" @default.
- Q51533517 description "научни чланак" @default.
- Q51533517 description "научни чланак" @default.
- Q51533517 description "מאמר מדעי" @default.
- Q51533517 description "مقالة علمية نشرت في 17 أكتوبر 2011" @default.
- Q51533517 description "১৭ অক্টোবর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q51533517 description "บทความทางวิทยาศาสตร์" @default.
- Q51533517 description "სამეცნიერო სტატია" @default.
- Q51533517 name "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 name "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 type Item @default.
- Q51533517 label "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 label "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 prefLabel "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 prefLabel "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 P1433 Q51533517-33FCADD3-E565-44D4-B6C0-709FED0C6BE6 @default.
- Q51533517 P1476 Q51533517-00164363-4C9A-4FCF-92D4-CA3EBA45B42B @default.
- Q51533517 P2093 Q51533517-4CF555C2-6529-467A-AD6C-2C51279F41BE @default.
- Q51533517 P2093 Q51533517-70E91E8E-8774-49BB-9045-4FE06694C976 @default.
- Q51533517 P2093 Q51533517-75B6B328-04BA-4039-9AC9-9DC574F8F96F @default.
- Q51533517 P2093 Q51533517-84155A5B-A3CF-490C-93EA-F3A601CAF029 @default.
- Q51533517 P2093 Q51533517-92F2FF4D-D7C0-41B4-A816-592B9027A034 @default.
- Q51533517 P2093 Q51533517-9D3AE037-7034-4FA1-B444-2F6AEF385DB6 @default.
- Q51533517 P2093 Q51533517-A996AFFC-1DFD-4CFD-BF40-96F42BF7D111 @default.
- Q51533517 P2093 Q51533517-B2E15754-9A01-445C-AA05-1DE2F18807DA @default.
- Q51533517 P2093 Q51533517-BCCBC542-B608-43EC-A156-08A01A2FB3DD @default.
- Q51533517 P304 Q51533517-058F3D28-93FB-42BA-A88F-237F0674D9BF @default.
- Q51533517 P31 Q51533517-1859BB5E-2717-4875-BBEE-B11E71BBD09A @default.
- Q51533517 P356 Q51533517-F33259E8-69F9-4401-AAEC-E8A341BEA3D9 @default.
- Q51533517 P433 Q51533517-82CF0E92-D802-4CB4-8515-7035CF072355 @default.
- Q51533517 P478 Q51533517-E7BD8CEA-7DA7-4534-BB54-C672F43591B1 @default.
- Q51533517 P50 Q51533517-BE32FE2E-3EEE-49F8-98BB-E917F65631E4 @default.
- Q51533517 P50 Q51533517-EE52D2CA-C017-40E1-BF52-AB4EC5AF0772 @default.
- Q51533517 P577 Q51533517-B84CBC42-17A0-4322-A2EC-B3BCDED8267F @default.
- Q51533517 P698 Q51533517-06FC23FC-58D4-4555-A1B7-4378EE7CE475 @default.
- Q51533517 P921 Q51533517-E9C57204-F854-4F07-A31C-B8BD6C48BF9D @default.
- Q51533517 P921 Q51533517-F1A9CC91-A529-4B64-908D-EA3429BB8C1A @default.
- Q51533517 P356 AID.2011.0050 @default.
- Q51533517 P698 21902621 @default.
- Q51533517 P1433 Q4651880 @default.
- Q51533517 P1476 "Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial." @default.
- Q51533517 P2093 "Aimee Wilkin" @default.
- Q51533517 P2093 "Anton L Pozniak" @default.
- Q51533517 P2093 "Javier Morales-Ramirez" @default.
- Q51533517 P2093 "Katia Boven" @default.
- Q51533517 P2093 "Laurence T Rimsky" @default.
- Q51533517 P2093 "Mario Santoscoy" @default.
- Q51533517 P2093 "Sergio H Lupo" @default.
- Q51533517 P2093 "Simon Vanveggel" @default.
- Q51533517 P2093 "TMC278-C204 Study Group" @default.